ERBB2 and breast carcinoma: Breast cancer is a heterogeneous disease that can be classified into different subtypes based on immunohistochemical markers (IHC) [1,2,3] such as the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the proliferation marker Ki67.